Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > BioForce Nanosciences Pursues Support for ViriChip(TM) Platform

BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc.
(OTC Bulletin Board: BFNH), continues their effort to fund development of
the ViriChip(TM) platform, a patented system designed to rapidly and
nondestructively detect and identify whole viruses. Developed by BioForce
and made possible by BioForce's Nano eNabler(TM) molecular printer, the
ViriChip platform can have a major impact in biodefense by creating
ultraminiaturized biodetection devices.

BioForce Nanosciences Pursues Support for ViriChip(TM) Platform

AMES, IA | Posted on April 11th, 2007

BioForce Nanosciences has three major product focus areas: 1)
instrumentation, 2) consumables, and 3) applications. The ViriChip platform
is just one application that BioForce's R&D department has developed using
the Nano eNabler system. The ViriChip technology is sensitive and specific
enough to detect a variety of different pathogens based on the availability
of capture reagents. These could include environmental pathogens
(Noroviruses, coxsackieviruses, etc.), pathogens relevant to biodefense
(smallpox, hemorrhagic fever viruses), animal and plant viruses (foot and
mouth disease, rinderpest, Avian influenza, West Nile), and human disease
agents (Human papillomavirus, herpes viruses, SARS).

BioForce Nanosciences is working to gain government and other support
for the ViriChip platform to assist with biodefense, food safety, and
pandemic diseases. "We want to create opportunities to inform scientific
leaders and decision makers about the importance of nanotechnology in the
life sciences," says Dr. Eric Henderson, BioForce's founder and chief
executive officer. "We believe that the technology embodied in our recently
released Nano eNabler(TM) system has the potential to impact nanotechnology
in the life sciences in a profound way."


About BioForce Nanosciences, Inc.
BioForce Nanosciences, Inc. is a wholly owned subsidiary of BioForce
Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH). BioForce
Nanosciences is a unique company entering into commercialization with over
a decade of research and accomplishment in the field of bionanotechnology.
BioForce has demonstrated the ability to take a product from concept to
commercial sale. For more information, visit .

This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in the Company's most recent filings with the
Securities and Exchange Commission. The Company's actual results could
differ materially from such forward-looking statements. We assume no duty
to update these statements at any future date.

For more information, please click here

BioForce Nanosciences, Inc.
1615 Golden Aspen Drive, Suite 101
Ames, IA 50010 USA

Phone: 515.233.8333
Fax: 515.233.8337

Investor Relations
Phone: 515.233.8333 ext. 101
Fax: 515.233.8337

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Nanometrics Announces Upcoming Investor Events November 18th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces Multi-Year Agreement With Lockheed Martin November 16th, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA November 16th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces the Sale of Its Latest Quantum Computer to Los Alamos National Laboratory November 11th, 2015


Nanoparticles simplify DNA identification and quantification November 27th, 2015

Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015

Electric fields remove nanoparticles from blood with ease November 24th, 2015

Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015


'Material universe' yields surprising new particle November 28th, 2015

Iranian Scientists Discover New Catalyst to Remove Pharmaceutical Compounds from Wastewater November 28th, 2015

RAMAN Spectrometry Makes Characterization of Various Nanostructures Possible November 28th, 2015

Nanoparticles Boost Impact Resistance of Special Type of Polymer November 28th, 2015

Homeland Security

Nanoparticle delivery maximizes drug defense against bioterrorism agent: UCLA team develops method for improving drug’s efficacy while reducing side effects November 6th, 2015

Toward clearer, cheaper imaging of ultrafast phenomena: A new, all-optical method for compressing narrow electron pulses to a billionth of a billionth of a second could improve real-time movies of chemical reactions and other ultrafast processes October 14th, 2015

Nanopaper as an optical sensing platform July 23rd, 2015

Iranian Scientists Design Nano Device to Detect Cyanogen Toxic Gas June 23rd, 2015


'Material universe' yields surprising new particle November 28th, 2015

Nanoparticles Boost Impact Resistance of Special Type of Polymer November 28th, 2015

UMD & Army researchers discover salty solution to better, safer batteries: Greatest potential uses seen in safety-critical, automotive and grid-storage applications November 21st, 2015

Navy researchers recruit luminescent nanoparticles to image brain function November 19th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic